Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RCVS issues guidance after reclassification of drugs
Drugs
The RCVS has issued advice for practitioners about the use of ketamine and tramadol.

Regulatory changes mean new prescription requirements for tramadol  

The RCVS has issued advice for vets following the reclassification of ketamine and tramadol. 
 
Regulatory changes mean that tramadol is now classified as a controlled drug, and has been added to Schedule 3 of the Misuse of Drugs Regulation 2001. This change was made effective by the Home Office as of June 10, 2014.
 
Practitioners should be aware that as a Schedule 3 controlled drug, tramadol is now subject to special requirements when writing prescriptions:
 
  • Prescriptions for Schedule 3 controlled drugs are only valid for 28 days and are non-repeatable
  • It is an offence to supply a Schedule 3 controlled drug against a fax or email prescription; the original prescription must be obtained before the medicine is dispensed
  • If supplying a Schedule 3 controlled drug against another veterinary surgeon’s prescription, checks need to be made to ensure that the prescription has come from a UK address and that the signature is genuine
  • The date on which the drug was supplied must be marked on the prescription and the prescription retained on the practice premises for at least five years

The RCVS also advises that despite being exempt from Safe Custody Regulations, all Schedule 3 controlled drugs should be locked away. 

Ketamine has also been reclassified as a Class B controlled drug. It remains under Schedule 4 of the 2001 regulations, meaning that the legal requirements for supply, storage and record keeping should remain the same.
 
The RCVS therefore continues to advise that practice premises should:

  • Record the use of ketamine in an informal register
  • Store ketamine in a controlled drugs cabinet
  • Destroy ketamine in the presence of an authorised witness
 
For further information about the specific requirements for controlled drugs, see the Veterinary Medicines Directorate’s Guidance Note No 20 - Controlled Drugs.
 
Practice premises can also contact the RCVS professional conduct department for further guidance on 020 7202 0789 or by email.

 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.